Roche Files 3 Patent Suits Over Generic Xeloda
Hoffmann-La Roche Inc. sued Intas Pharmaceuticals Ltd. on Friday in an effort to protect the market for the cancer drug Xeloda, marking the third patent suit over Xeloda that Roche filed...To view the full article, register now.
Already a subscriber? Click here to view full article